MK-458, A SELECTIVE AND POTENT D2 RECEPTOR AGONIST IN ADVANCED PARKINSONS-DISEASE

被引：9
|
作者：
LIEBERMAN, A [1 ]
CHIN, L [1 ]
BAUMANN, G [1 ]
机构：
[1] NEW YORK INFIRM BEEKMAN DOWNTOWN MED CTR,DEPT SURG,NEW YORK,NY
来源：
CLINICAL NEUROPHARMACOLOGY | 1988年 / 11卷 / 03期
关键词：
D O I：
10.1097/00002826-198806000-00001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：191 / 200
页数：10
相关论文
共 50 条
  • [31] TREATMENT OF PARKINSONS-DISEASE WITH NOVEL DOPAMINE-D2 AGONIST SK-AND-F-101468
    KAPOOR, R
    PIRTOSEK, Z
    FRANKEL, JP
    STERN, GM
    LEES, AJ
    BOTTOMLEY, JM
    HARAN, NS
    LANCET, 1989, 1 (8652): : 1445 - 1446
  • [32] COMPARATIVE PET STUDIES OF STRIATAL GLUCOSE AND DOPA METABOLISM AND DOPAMINE D2 RECEPTOR-BINDING IN PATIENTS WITH PARKINSONS-DISEASE (PD)
    ANTONINI, A
    VONTOBEL, P
    PSYLLA, M
    GUNTHER, I
    LEENDERS, KL
    NEUROLOGY, 1995, 45 (04) : A409 - A409
  • [33] STRIATAL DOPAMINE D2 RECEPTORS IN DOPA-RESPONSIVE DYSTONIA (DRD) AND PARKINSONS-DISEASE (PD)
    MEINCK, HM
    LEENDERS, KL
    ANTONINI, A
    NEUROLOGY, 1995, 45 (04) : A219 - A219
  • [34] DOPAMINE-RECEPTOR SUBTYPE-SELECTIVE AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE
    CHASE, TN
    METMAN, LV
    BRAVI, D
    ROBERTS, JW
    SIBLEY, DR
    MOURADIAN, MM
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 : S207 - S215
  • [35] WEARING-OFF AND BETA-2-ADRENOCEPTOR AGONIST IN PARKINSONS-DISEASE
    HISHIDA, R
    KURAHASHI, K
    NARITA, S
    BABA, T
    MATSUNAGA, M
    LANCET, 1992, 339 (8797): : 870 - 870
  • [36] THERAPEUTIC EXPERIENCE WITH THE NEW DOPAMINE AGONIST CU-32-085 IN ADVANCED PARKINSONS-DISEASE
    BIESEMEYER, H
    LUDIN, HP
    RINGWALD, E
    JOURNAL OF NEUROLOGY, 1983, 230 (01) : 19 - 23
  • [37] D-1 AND D-2 AGONISTS IN PARKINSONS-DISEASE
    LIEBERMAN, AN
    GOLDSTEIN, M
    GOPINATHAN, G
    NEOPHYTIDES, A
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 466 - 473
  • [38] Sumanirole: The first highly A D2 selective dopamine receptor agonist intended for the treatment of Parkinson's disease
    McCall, RB
    Nichols, NF
    Svensson, KA
    Meglasson, MD
    Huff, RM
    MOVEMENT DISORDERS, 2002, 17 : S50 - S50
  • [39] BENEFICIAL EFFECT OF CABERGOLINE, NEW LONG-LASTING D-2 AGONIST IN THE TREATMENT OF PARKINSONS-DISEASE
    RABEY, JM
    NISSIPEANU, P
    INZELBERG, R
    KORCZYN, AD
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 (03) : 286 - 293
  • [40] SYNTHESIS AND RADIORECEPTOR BINDING-ACTIVITY OF N-0437, A NEW, EXTREMELY POTENT AND SELECTIVE D2 DOPAMINE RECEPTOR AGONIST
    HORN, AS
    TEPPER, P
    VANDERWEIDE, J
    WATANABE, M
    GRIGORIADIS, D
    SEEMAN, P
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (05) : 208 - 211
12345